CSF analysis is used to diagnose a wide variety of neurodegenerative disorders.
CSF tests provide insights into understanding the pathology related to dementia.
Ongoing research identifies new CSF biomarkers of clinical relevance.
Alterations in patterns of proteins, metabolites, DNA/RNA and seeding techniques are explored.
Robust and specific biomarkers for disease prognosis are required.